600079 ST人福医药
2026/09 - 九个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)12.29410.1567.67113.30717.753
总资产报酬率 ROA (%)6.4865.0663.6585.9106.955
投入资产回报率 ROIC (%)8.4136.5824.7757.8039.179

边际利润分析
销售毛利率 (%)49.80348.21444.55345.80643.525
营业利润率 (%)19.18913.3469.91514.05615.740
息税前利润/营业总收入 (%)20.48514.02110.90415.03916.398
净利润/营业总收入 (%)15.98910.4026.99211.47913.749

收益指标分析
经营活动净收益/利润总额(%)79.793108.568114.31391.83972.560
价值变动净收益/利润总额(%)20.2803.69310.14510.15525.656
营业外收支净额/利润总额(%)-1.286-4.626-4.094-1.872-2.626

偿债能力分析
流动比率 (X)2.0751.8331.4891.4851.283
速动比率 (X)1.7351.5351.2211.2111.057
资产负债率 (%)37.25540.11243.32044.48650.192
带息债务/全部投入资本 (%)25.89529.42032.33534.21940.188
股东权益/带息债务 (%)271.516226.129195.060179.446138.821
股东权益/负债合计 (%)144.977128.321111.435105.82383.166
利息保障倍数 (X)13.30211.0827.90812.11215.459

营运能力分析
应收账款周转天数 (天)145.319139.676122.512114.800115.106
存货周转天数 (天)101.952100.10791.70795.33893.421